Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk in older patients with hypertension remains unclear. Methods In this multicenter, randomized, controlled trial, we assigned Chinese patients 60 to 80 years of age with hypertension to a systolic blood-pressure target of 110 to less than 130 mm Hg (intensive treatment) or a target of 130 to less than 150 mm Hg (standard treatment). The primary outcome was a composite of stroke, acute coronary syndrome (acute myocardial infarction and hospitalization for unstable angina), acute decompensated heart failure, coronary revascularization, atrial fibrillation, or death from cardiovascular causes. Results Of the 9624 patients screened for eligibility, 8511 were enrolled in the trial; 4243 were randomly assigned to the intensive-treatment group and 4268 to the standard-treatment group. At 1 year of follow-up, the mean systolic blood pressure was 127.5 mm Hg in the intensive-treatment group and 135.3 mm Hg in the standard-treatment group. During a median follow-up period of 3.34 years, primary-outcome events occurred in 147 patients (3.5%) in the intensive-treatment group, as compared with 196 patients (4.6%) in the standard-treatment group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.92; P = 0.007). The results for most of the individual components of the primary outcome also favored intensive treatment: the hazard ratio for stroke was 0.67 (95% CI, 0.47 to 0.97), acute coronary…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial included nearly 20% of people with diabetes and noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (39).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [39]
In the citing paper
“Participants with diabetes comprised nearly 20% of the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, which noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (41).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [41]
In the citing paper
“Hypotension occurred more frequently in the intensive treatment group (3.4%) compared with the standard treatment group (2.6%), without signi fi cant differences in other adverse events, including dizziness, syncope, or fractures.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, the primary composite outcome of stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fi brillation, or death from cardiovascular causes was reduced by 26% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, 18.9% of patients in the intensive treatment arm and 19.4% in the standard treatment arm had a diagnosis of type 2 diabetes.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Cited by
Items 601–700 of 805
Ist die Blutdruckselbstmessung sinnvoll?
Westhoff, T. H., & Middeke, M. (2022) · CardioVasc · doi:10.1007/s15027-021-3625-y
Coca, A., & Camafort, M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac050
Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2021
Wingo, M. T., Huber, J. M., Bornstein, S. L., Sundsted, K. K., Mauck, K. F., Szostek, J. H., Post, J. A., & Wieland, M. L. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.02.043 · Cited by 1
Kario, K. (2022) · Current Hypertension Reviews · doi:10.2174/157340211801220607103646
Self-citationConservative versus aggressive blood pressure reduction: Do we have a winner?
Lović, D. B., & Doumas, M. N. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.027
Kjeldsen, S. E., Egan, B. M., Narkiewicz, K., Kreutz, R. H., Burnier, M., & Oparil, S. (2022) · Blood Pressure · doi:10.1080/08037051.2022.2083578
Should Low Diastolic Blood Pressure Level Be a Barrier to Intensive Blood Pressure Lowering?
Muntner, P., & Rahimi, K. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac076
The Prevention of the New Onset of Heart Failure in Hypertensive Patients
Kiuchi, S., & Ikeda, T. (2022) · Internal Medicine · doi:10.2169/internalmedicine.0799-22
Highlights du congrès 2022 de la Société suisse de médecine interne générale: partie 1
Mouraux, S., Cuéllar, S. I. G., Crausaz, L., Delabays, B., & Cominetti, F. (2022) · JMIG · doi:10.53738/revmed.2022.18.805.2196
Bahat, G., Özkök, S., Petrović, M., & Benetos, A. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003295
Siński, M., Berka, P., Lewandowski, J., Sobieraj, P., Piechocki, K., Paleczny, B., & Siennicka, A. E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247454
Treatment of hypertension in elderly
Joo, S., & Kim, D. (2022) · Journal of Medicine and Life Science · doi:10.22730/jmls.2022.19.3.79
Association of serum uric acid with benefits of intensive blood pressure control
Wang, X., Tan, J., Zhang, S., Zhang, W.-L., & Cai, J. (2023) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2023.01.003
Self-citationWang, X., Tan, J., Zhang, S.-Y., Zhang, W., & Cai, J. (2023) · Revista Española de Cardiología · doi:10.1016/j.recesp.2023.01.003
Self-citation[Which blood pressure target for the frail older patient?]
Claassen, J. A. H. R., Richard, E., Mooijaart, S. P., & van Charante, E. P. M. (2023) · PubMed
Ryu, S. I., Kim, Y.-D., Kim, T., Ban, S. P., Bang, J. S., Kwon, O.-K., Oh, C. W., & Lee, S. U. (2023) · Research Square · doi:10.21203/rs.3.rs-2611843/v1
Zou, J., Wang, Q., Chen, Y., Zhou, J., Liu, R., Xu, Y., Peng, M., Li, X., Liu, M., & Jiang, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2823701/v1
Self-citationSchneider, M. P. (2023) · Springer eBooks · doi:10.1007/978-3-662-65648-8_24
Domínguez, D. M., Gómez-Sánchez, L., Gallego-Fernández, V., Seoane‐Pillado, T., & López-Álvarez, X. L. (2023) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2023.101999
Li, X., Xu, W., Mo, X., Wu, F., Qu, M., Ye, J., Wu, W., Li, H., & Li, T. (2023) · Health and Quality of Life Outcomes · doi:10.1186/s12955-023-02168-0
Li, C., Yang, C., Shao, F., Liang, X., Chen, K., Yang, T., Wu, Z., Shi, G., & Chen, T. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04100
Assessing Risk and Preventing Nonmechanical Falls
Fadem, S. Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-39155-2_5
2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
Yang, Y. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.3.135
Hypertonia és nefroprotekció időskorban
Dolgos, S., & Huszár, L. (2023) · Lege Artis Medicinae · doi:10.33616/lam.33.0417
The Effect of Blood Pressure on the Prognosis of Cardiovascular Disease
斯米力, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13112450
Esau, D., & Abramson, B. L. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_8
Xu, D., Dai, X., Yang, Q., Li, X., Xiao, Y., Huang, Q., & Lou, Q. (2023) · International Journal of Endocrinology · doi:10.1155/2023/1057121
“…by continuous high-pressure blood fow can be reduced, and atherosclerotic plaque formation can also be reduced when the blood pressure of hypertensive individuals is managed below 140/ 90 mmHg [22], thereby reducing the incidence of ischemic stroke [23] and acute myocardial infarction [24].”
BackgroundRecent Insights on Blood-Pressure Control Goals and Management for the Elderly
Park, S. (2023) · 대한임상노인의학회지 · doi:10.15656/kjcg.2023.24.3.100
Is it time to recommend cardiovascular protection for all?
Greenstein, A. S., Reusch, J. E. B., & Heagerty, A. M. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003501
Balletshofer, B. M., Böckler, D., Diener, H., Heckenkamp, J., Ito, W. D., Katoh, M., Lawall, H., Malyar, N. M., Qiu, H. J., Reimer, P., et al. (2024) · Die Diabetologie · doi:10.1007/s11428-023-01141-1
“In einigen Studien war eine intensivierte Blut-drucktherapie mit einer niedrigen kardio-vaskulären Ereignisrate assoziiert [15, 16].”
Hypertonietherapie bei Nierenerkrankungen: Wie den Blutdruck optimal in den CKD-Stadien senken?
Boger, L., & Saritas, T. (2024) · Nephrologie aktuell · doi:10.1055/a-2215-3675
Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
Wilson, D. P., Hamilton, L., & Maki, K. C. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_14
Blood Pressure and Cardiovascular Outcomes
Greenstein, S. A., & Diamond, J. A. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_12
Cập nhật quản lý tăng huyết áp ở người cao tuổi
Ngô, H. T., Kim, S. T., & Huỳnh, V. M. (2024) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.109.2024.837
Grupp, C. (2024) · Springer Reference Medizin · doi:10.1007/978-3-642-54676-1_72-2
Narita, K., & Kario, K. (2024) · Hypertension Research · doi:10.1038/s41440-024-01803-7
Self-citationRanawaka, U. K. (2024) · Journal of the Ceylon College of Physicians · doi:10.4038/jccp.v55i1.8017
A diasztolés vérnyomás összefüggése a cardiovascularis betegségekkel
Kékes, E., & Vályi, P. (2024) · Lege Artis Medicinae · doi:10.33616/lam.34.0373
Managing hypertension in older people: current concepts
Steckelmacher, J., Graham, C., Maniero, C., & Gupta, A. K. (2024) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2023.000031
Hypertension Along Women’s Life Course
Kringeland, E. A., & Gerdts, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-65952-2_7
Zhou, Z., Miao, H., Yang, S., Yin, Z., Chen, Y., & Zhang, Y. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14903
Self-citationYamamoto, K. I. (2024) · Hypertension Research · doi:10.1038/s41440-024-01957-4
New ESC guidelines on hypertension: key messages
Medovchshikov, V., Tlegenova, Z. S., & Yeshniyazov, N. (2024) · Heart Vessels and Transplantation · doi:10.24969/hvt.2017.524
Huang, F., Wang, C., Yan, Y., & Hu, K. (2024) · American Journal of Translational Research · doi:10.62347/okxs1649
Li, Q., Wang, P., Sun, Y., Chen, Y., & Zhang, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-79189-2
Self-citationSchulze-Bauer, H., Staudacher, M., Steiner, S., & Schlager, O. (2024) · Herz · doi:10.1007/s00059-024-05286-7
Ahmed, S., & Hiremath, S. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-68460-9_7
Shen, N. M., Wanigatunga, A. A., Michos, E. D., Ambrosius, W. T., & Lesko, C. R. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae474
Análise da relação entre a Hipertensão Arterial e a Doença Arterial Coronariana
Andrade, M. M. D. M. S., de Oliveira, V. A., Nobre, A. T. D. A., Alves, M. E. B. S., Santos, L. V. M., Quintela, W. L., Sandes, M. E. S., Santos, A. G., & Burgos, Ú. M. M. C. (2025) · Revista JRG de Estudos Acadêmicos · doi:10.55892/jrg.v8i18.1798
Blood pressure control among Veterans with high cardiovascular disease risk
Zghayer, A., O’Halloran, M., Stroupe, K. T., Huo, Z., Weaver, F. M., Hughes, A. M., Markossian, T. W., Neddy, R., & Kramer, H. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100943
“In clinical trials, an average of one additional BP lowering medication is required to obtain a SBP target goal of 130 mmHg compared to 140 mmHg [21 – 24].”
Pangestuti, D., Lubis, A., Lubis, A. R. B., Mukminin, A., Dania, I. A., Saputra, D. A., & Sajow, H. S. (2025) · Jurnal Ilmiah Ilmu Terapan Universitas Jambi|JIITUJ| · doi:10.22437/jiituj.v9i1.34442
Zhang, D., Zhang, Y., An, D., Cheng, Y., Tang, S., Liu, M., Li, J., Staessen, J. A., Wang, J., Li, Y., et al. (2025) · Blood Pressure · doi:10.1080/08037051.2025.2472192
Self-citationBPROAD — End of the Road for Debate on Systolic Blood-Pressure Goals in Type 2 Diabetes?
Anand, S., & Beddhu, S. (2025) · New England Journal of Medicine · doi:10.1056/nejme2501656
Sung, D.-E., Kang, J., Lee, E. M., & Sung, K.-C. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf012
Saeed, Y., Tariq, H., Fakhar, A., Chaudhary, M. O. A., Khan, M. T., & Irfan, U. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i4.1005
History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease
Abramovitz, B., Hossain, A., Byfield, R. L., & Cohen, J. B. (2025) · Cardiology Clinics · doi:10.1016/j.ccl.2025.03.003
Chen, Y.-T., & Cheng, H. (2025) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000745
Self-citationChatzikyrkou, C., & Mertens, P. R. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21183-6.00018-0
Lipitension today — disaster tomorrow: focus on elderly comorbid patients
Скотников, А. С., Дмитриевич, З. В., Gvozdeva, A. D., & Бектемирова, Л. Г. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6340
Balletshofer, B. M., Böckler, D., Diener, H., Heckenkamp, J., Ito, W. D., Katoh, M., Lawall, H., Malyar, N. M., Qiu, H. J., Reimer, P., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01323-z
Detection and Follow-Up of Hypertension and Synopsis of Guideline Recommendation
Jones, K. M. (2025) · Nephrology Self-Assessment Program · doi:10.58483/nsap.00032025
The Impact of Smart Management Model on Blood Pressure Control Rate in Elderly Hypertensive Patients
孙, 浩. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551670
Huang, M., & Hu, R. (2024) · Asian Conference on Artificial Intelligence Technology (ACAIT) · doi:10.1109/acait63902.2024.11021844
Does intense blood pressure control in older patients improve outcomes?
Lay, B., Pooni, J., Budreau, G., & Prieto, D. G. (2025) · Evidence-Based Practice · doi:10.1097/ebp.0000000000002460
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770-f · Cited by 1
Tantirige, N. N., & Wilkinson, I. B. (2025) · British Journal of Cardiology · doi:10.5837/bjc.2025.036
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251352537
Wang, C., Tang, H., Yang, Q., Lu, Y., Lin, Z., & Zhang, Y. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05373-1
Rakibul-Hasan, M., Yeasna, K. F., & Mohana, C. A. (2025) · Cureus · doi:10.7759/cureus.90839
“These results underscore the need for aggressive SBP management, especially considering its well-established role in cardiovascular risk among older adults [11,12].”
Gibt es pflanzliche Alternativen zu chemisch definierten Antihypertensiva?
Kraft, K. (2025) · Zeitschrift für Phytotherapie · doi:10.1055/a-2534-4691
Optional hypertension: a new concept emerging from trials of intensive blood pressure control
McEvoy, J. W. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01670-8
Verdecchia, P., Angeli, F., & Reboldi, G. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25902
Blood Pressure and Risk of Clinical Events in Peripheral Artery DiseasePreprint
Girotra, S. R., Vaughan‐Sarrazin, M., de Lemos, J. A., Chan, P. S., Gupta, A. K., Li, Q., Nguyen, C., Lund, B. C., Nathani, R., Hoffman, R. M., et al. (2025) · medRxiv · doi:10.1101/2025.09.29.25336935
Muntner, P., & Schiffrin, E. L. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf181 · Cited by 2
ADHERENCIA TERAPÉUTICA EN ADULTOS MAYORES CON HIPERTENSIÓN ARTERIAL
Guevara, G. M. G., Cruz, M. G. C., Guzman, A., Maldonado-Muñiz, G., & Sánchez, A. M. (2025) · Revista Foco · doi:10.54751/revistafoco.v18n10-015
Aldalaan, T. A., Abriya, Z. A. R. A., Almutairi, A. F., Alsadah, M. R., Alamer, K. R. M., Alamer, N. M. A., Alahmed, M. J. M., Almizraq Huda Abdulaziz, J., Alsalman, F., Alqari, H. H., et al. (2025) · International Journal of Computational and Experimental Science and Engineering · doi:10.22399/ijcesen.4046
Lee, E. M., Cho, I., Kim, H. J., Kim, D., Lee, H., Park, S., & Ihm, S. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e31
Evaluating methods for the prevention of cognitive decline and dementia
den Brok, M. (2025) · Radboud University Press eBooks · doi:10.54195/9789465150345
The Systolic Blood Pressure Intervention Trial
Wright, J. T., & Rahman, M. U. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.076
Won, K., Choi, S.-Y., Chun, E. J., Park, S. H., Sung, J., Jung, H. O., & Chang, H. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103993
van der Giet, M. (2025) · Nephrologie aktuell · doi:10.1055/a-2624-0883
Frazier, C. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch20
Cardiovascular Disease and Risk Management
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch17
Updates on the Clinical Management of Hypertension: A Narrative Review
Sanyaolu, S. E., Sowunmi, A., Kadejo, P. Z., Mabadeje, R. A., Sotannde, A. A., & Wilson, D. O. (2025) · Premier journal of science. · doi:10.70389/pjs.100158
Gilyarevskiy, S. R., Shchedrina, A. Y., & Golshmid, M. V. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-444
Mariampillai, J. E., Heimark, S., Kjeldsen, S. E., & Devereux, R. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33927-1.00010-9
Hypertensive medications for older persons
Canoy, D., & Barker, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29025-1.00008-4
Normalwert, Optimalwert, Zielwert... the lower, the better?
Muders, D., & Halbach, M. (2025) · Aktuelle Kardiologie · doi:10.1055/a-2708-1540
“Aktuelle randomisierte Studien belegen den Nutzen einer frühen Therapieinitiierung und niedrigerer Zielwerte < 130 mmHg.”
Frontline advancement: Insights from the 2025 Canadian Hypertension Guidelines
Yang, N. (2025) · Cardiac Research · doi:10.1097/re9.0000000000000007
A systematic review of commencing full-dose antihypertensives in newly diagnosed hypertension
Karavadra, B., d’Elia, A., Shantsila, A., Lip, G. Y. H., & Shantsila, E. (2025) · Blood Pressure · doi:10.1080/08037051.2025.2594268
New Concepts in Cardiac Rehabilitation and Secondary Prevention After Acute Coronary Syndrome
Zwisler, A., & Taylor, R. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11869-2.00029-1
Oliveira, M. G., MEIRELES, S., Moreira, P. M., Costa, M. C., Bortolotto, L. A., Amorim, W. W., Ribeiro, A. L. P., Boockvar, K. S., & Santos, P. D. M. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03950-3
Sakamoto, D., Sotomi, Y., Okada, K., Konishi, S., Takeda, T., Sakata, Y., Matoba, T., Kohro, T., Oba, Y., Kabutoya, T., et al. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004213
Self-citationWeekly Journal Scan: Exploring the balance of benefits and harms of intensive blood pressure control
Pedicino, D., & Volpe, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf968
Qiu, W., Cai, A., Li, L., & Feng, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25687397
Self-citationSong, Q., Ling, Q., Bai, J., Zhang, H., Bu, P., Chen, F., Wu, S., Zhang, W., Chen, M., & Cai, J. (2022) · Figshare · doi:10.6084/m9.figshare.21366054
Self-citationLi, X., Xu, W., Mo, X., Wu, F., Qu, M., Ye, J., Wu, W., Li, H., & Li, T. (2024) · Figshare · doi:10.6084/m9.figshare.26611205
Li, X., Xu, W., Mo, X., Wu, F., Qu, M., Ye, J., Wu, W., Li, H., & Li, T. (2024) · Figshare · doi:10.6084/m9.figshare.26611202
Yu, Y., Gu, M., Huang, H., Cheng, S., Deng, Y., Cai, C., Chen, X., Niu, H., Ning, X., & Hua, W. (2022) · Figshare · doi:10.6084/m9.figshare.21376213
Self-citation
Metadata
- Authors
- Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, G., Yang, J., Jiang, Y., Xu, X., Wang, T.-D., Chen, Y., Li, Y., Yao, L., Li, D., Wang, L., Shen, X., Yin, X., Liu, W., Zhou, X., Zhu, B., Guo, Z., Liu, H., Chen, X., Feng, Y., Tian, G., Gao, X., Kario, K., & Cai, J.
- Affiliations
- Shanxi Medical University (CN)
- Hebei North University (CN)
- Omron (Japan) (JP)
- Jichi Medical University (JP)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1268-1279
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198533772
- Cited by
- 784
- References
- 47
- Citations by year
- 2026: 131 · 2025: 196 · 2024: 146 · 2023: 134 · 2022: 154 · 2021: 23
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81630014, 81825002)
- Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023029)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-006, CI2021A00920)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- intensive blood pressure control, systolic blood pressure target, older adults, hypertension, cardiovascular risk reduction, stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fibrillation, cardiovascular mortality, renal outcomes, antihypertensive therapy, Chinese patients, SPRINT trial
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Hypotension, Male, Middle Aged, Systole, Incidence, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.